AlaxoLito Nasal Stent for splinting of the nasal passage
The AlaxoLito Nasal Stent mechanically splints the nasal valve, the nasal alar, and the nasal passage. Due to the shape of the nitinol braid, stable positioning is achieved within the nose, and the stent is secured. The nasal valve and the nasal alar are efficiently splinted by the ball-shaped part of the stent. The stent creates an optimal opening so that a healthy airway is achieved.
The AlaxoLito Nasal Stent significantly improves the fluid mechanics in the nose leading to a reduction of flow noise. As a result of optimized oxygen and nitric oxide supply, sleep becomes healthier, more relaxed, and more restful.
The AlaxoLito Nasal Stent is clinically tested and is a prescription medical device. The stent is self-applied by the patient and can be worn for up to 18 hours.
The AlaxoLito Nasal Stent is used to splint the anterior nasal passage. The AlaxoLito Nasal Stent splints about one third to one half of the turbinate, dependent on the length of the turbinate and anatomy of the individual patient.
The AlaxoLito Plus splints the entire nasal passage. It provides high performance and splints the complete turbinate.
The AlaxoLito Sport is made of a stiffer nitinol braid and splints the entire nasal passage. The stiffer braid maintains splinting of the nasal passage during intense exercise optimizing nasal breathing.
The AlaxoStent mechanically splints the airway in the velopharynx. It has been optimized in such a way that during application of the stent, force is evenly applied across the tulip (the wider section of the stent).
The AlaxoStent as an alternative therapy for obstructive sleep apnea
The AlaxoStent mechanically splints the airway in the velopharynx. It has been optimized in such a way that during application of the stent, force is evenly applied across the tulip (the wider section of the stent). As a result, optimal functionality in splinting the velopharnygeal soft tissue is achieved.
The tulip is positioned in the velopharynx so that the soft palate and the posterior and lateral walls are splinted. Thus, a velopharyngeal collapse is prevented.
The AlaxoStent is clinically tested for treatment of patients with obstructive sleep apnea or snoring. It is self-applied by the patient and can be worn for up to 18 hours.